Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 33 clinical trials
A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

The main purpose of this study is to measure the amount of lopinavir/ritonavir (two anti-HIV medications) in the blood. Results from this study will be compared to the levels of the drugs

HIV Vaccine
ritonavir
kaletra
lopinavir
lopinavir/ritonavir
  • 340 views
  • 08 Nov, 2020
  • 57 locations
Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV

The purpose of this study is to see if emtricitabine is safe in children infected with HIV and to determine the best dose.

emtricitabine
stavudine
lopinavir/ritonavir
ritonavir
lopinavir
  • 151 views
  • 07 Nov, 2020
  • 2 locations
HIV Antiretroviral Drugs and Metabolism

will be studied before and at the end of four weeks of taking ritonavir, lopinavir/ritonavir or atazanavir/ritonavir. Hypothesis 2: NNRTI drugs do not increase HDL by increasing apo AI

ritonavir
atazanavir
lopinavir
antiretroviral agents
efavirenz
  • 6 views
  • 07 Nov, 2020
  • 1 location
IFN Beta-1b and Ribavirin for Covid-19

As of 1 July 2020, more than 10 million people been confirmed to have infected by SARS-CoV-2, resulting in more than 500,000 deaths. No specific antiviral treatment for the SARS-CoV-2 is currently available, but existing medication could be repurposed. The investigators therefore propose to conduct an open-label randomized controlled trial …

SARS
interferon
critical illness
antiviral drugs
  • 0 views
  • 24 Jan, 2021
  • 1 location
IFN-beta 1b and Remdesivir for COVID19

A 5-day combination of interferon -1b and remdesivir will expedite the recovery, suppress the viral load and shorten hospitalisation in patients with SARS-CoV-2 infection compare to the control arm

  • 0 views
  • 26 Jan, 2021
  • 1 location
PI Vs. NNRTI Based Therapy for HIV Advanced Disease

Ritonavir boosted protease inhibitor based therapy will have equivalent antiviral efficacy over 48 weeks compared to NNRTI based therapy in patients who are antiretroviral therapy naïve and initiate therapy with CD4 counts ≤ 200/mm3.

antiretroviral therapy
lamivudine
efavirenz
antiviral
lopinavir/ritonavir
  • 32 views
  • 07 Nov, 2020
  • 5 locations
COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir

COVID-19 has rapidly evolved into a generalized global pandemic. Post-exposure prophylaxis (PEP) against on COVID-19 was identified as an urgent research priority by the WHO, and lopinavir

lopinavir
lopinavir/ritonavir
covid-19
ritonavir
  • 57 views
  • 24 Jan, 2021
  • 4 locations
Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19

Blinded, multicenter, placebo-controlled, randomized clinical trial evaluating lopinavir/ritonavir vs placebo in early outpatient treatment of adults with COVID-19

dyspnea
respiratory tract infection
lopinavir/ritonavir
fatigue
covid-19
  • 94 views
  • 11 May, 2021
  • 6 locations
Randomised Evaluation of COVID-19 Therapy

RECOVERY is a randomised trial investigating whether treatment with Lopinavir-Ritonavir, Hydroxychloroquine, Corticosteroids, Azithromycin, Colchicine, IV Immunoglobulin (children only

hydroxychloroquine
pneumonia
covid-19
ritonavir
corticosteroids
  • 0 views
  • 13 May, 2021
  • 3 locations
Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia

, among them: Hydroxychloroquine (HCQ), Lopinavir/Ritonavir (Lop/r), Remdesivir, Favipavir, Emtricitabine/ Tenofovir acting over bacterial co-infection Azithromycin (Azithro), or modifying the

pao2
acute respiratory distress
pneumonia
diabetes
tocilizumab
  • 62 views
  • 04 Jun, 2021
  • 7 locations